Although in vivo analyses of endothelial dysfunction in APS have been reported, most research has been performed in vitro using models with endothelial cells exposed to either serum/plasma, monoclonal aPL, or IgGs isolated from APS patients [33,34,35]. The gene discussed is FASLG; the disease is endothelial dysfunction.